| Literature DB >> 24925919 |
J Bousquet1, A Addis2, I Adcock3, I Agache4, A Agusti5, A Alonso6, I Annesi-Maesano7, J M Anto8, C Bachert9, C E Baena-Cagnani10, C Bai11, A Baigenzhin12, C Barbara13, P J Barnes3, E D Bateman14, L Beck15, A Bedbrook16, E H Bel17, O Benezet18, K S Bennoor19, M Benson20, M Bernabeu-Wittel21, M Bewick22, C Bindslev-Jensen23, H Blain24, F Blasi25, M Bonini26, S Bonini27, L P Boulet28, A Bourdin29, R Bourret30, P J Bousquet7, C E Brightling31, A Briggs32, J Brozek33, R Buhl34, A Bush35, D Caimmi36, M Calderon37, P Calverley38, P A Camargos39, T Camuzat18, G W Canonica40, K H Carlsen41, T B Casale7, M Cazzola42, A M Cepeda Sarabia43, A Cesario44, Y Z Chen45, E Chkhartishvili46, N H Chavannes47, R Chiron36, A Chuchalin48, K F Chung3, L Cox49, G Crooks50, M G Crooks51, A A Cruz52, A Custovic53, R Dahl23, S E Dahlen54, F De Blay55, T Dedeu56, D Deleanu57, P Demoly58, P Devillier59, A Didier60, A T Dinh-Xuan61, R Djukanovic62, D Dokic63, H Douagui64, R Dubakiene65, S Eglin66, F Elliot67, R Emuzyte65, L Fabbri68, A Fink Wagner69, M Fletcher70, W J Fokkens71, J Fonseca72, A Franco73, P Frith74, A Furber75, M Gaga76, J Garcés77, J Garcia-Aymerich8, A Gamkrelidze78, S Gonzales-Diaz79, F Gouzi80, M A Guzmán81, T Haahtela82, D Harrison83, M Hayot24, L G Heaney84, J Heinrich85, P W Hellings86, J Hooper87, M Humbert88, M Hyland89, G Iaccarino90, D Jakovenko18, J R Jardim91, C Jeandel24, C Jenkins92, S L Johnston93, O Jonquet24, G Joos94, K S Jung95, O Kalayci96, S Karunanithi97, T Keil98, N Khaltaev99, V Kolek100, M L Kowalski101, I Kull102, P Kuna103, V Kvedariene104, L T Le105, K C Lodrup Carlsen41, R Louis106, W MacNee107, A Mair108, I Majer109, P Manning110, E de Manuel Keenoy111, M R Masjedi112, E Melen113, E Melo-Gomes13, A Menzies-Gow114, G Mercier24, J Mercier115, J P Michel116, N Miculinic117, F Mihaltan118, B Milenkovic119, M Molimard120, I Momas121, A Montilla-Santana122, M Morais-Almeida123, M Morgan124, M N'Diaye125, S Nafti126, K Nekam127, A Neou128, L Nicod129, R O'Hehir130, K Ohta131, P Paggiaro132, S Palkonen133, S Palmer134, N G Papadopoulos135, A Papi136, G Passalacqua40, I Pavord137, B Pigearias138, D Plavec139, D S Postma140, D Price141, K F Rabe142, F Radier Pontal18, J Redon143, S Rennard144, J Roberts145, J M Robine146, J Roca5, N Roche147, F Rodenas77, A Roggeri148, C Rolland149, J Rosado-Pinto150, D Ryan151, B Samolinski152, M Sanchez-Borges153, H J Schünemann154, A Sheikh155, M Shields156, N Siafakas157, Y Sibille158, T Similowski159, I Small160, O Sola-Morales161, T Sooronbaev162, R Stelmach163, P J Sterk17, T Stiris164, P Sud165, V Tellier166, T To167, A Todo-Bom168, M Triggiani169, R Valenta170, A L Valero5, A Valiulis171, E Valovirta172, E Van Ganse173, O Vandenplas174, T Vasankari175, J Vestbo176, G Vezzani177, G Viegi178, L Visier24, C Vogelmeier179, T Vontetsianos180, R Wagstaff181, U Wahn182, B Wallaert183, B Whalley89, M Wickman113, D M Williams184, N Wilson185, B P Yawn186, P K Yiallouros187, A Yorgancioglu188, O M Yusuf189, H J Zar190, N Zhong191, M Zidarn192, T Zuberbier128.
Abstract
The objective of Integrated Care Pathways for Airway Diseases (AIRWAYS-ICPs) is to launch a collaboration to develop multi-sectoral care pathways for chronic respiratory diseases in European countries and regions. AIRWAYS-ICPs has strategic relevance to the European Union Health Strategy and will add value to existing public health knowledge by: 1) proposing a common framework of care pathways for chronic respiratory diseases, which will facilitate comparability and trans-national initiatives; 2) informing cost-effective policy development, strengthening in particular those on smoking and environmental exposure; 3) aiding risk stratification in chronic disease patients, using a common strategy; 4) having a significant impact on the health of citizens in the short term (reduction of morbidity, improvement of education in children and of work in adults) and in the long-term (healthy ageing); 5) proposing a common simulation tool to assist physicians; and 6) ultimately reducing the healthcare burden (emergency visits, avoidable hospitalisations, disability and costs) while improving quality of life. In the longer term, the incidence of disease may be reduced by innovative prevention strategies. AIRWAYSICPs was initiated by Area 5 of the Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing. All stakeholders are involved (health and social care, patients, and policy makers).Entities:
Mesh：
Year: 2014 PMID： 24925919 DOI： 10.1183/09031936.00014614
Source DB: PubMed Journal: Eur Respir J ISSN： 0903-1936 Impact factor: 16.671